PAXMEDICA INC (PXMD) Forecast, Price Target & Analyst Ratings
NASDAQ:PXMD • US70424C2035
0.6883 USD
-0.06 (-7.61%)
At close: May 1, 2024
0.37 USD
-0.32 (-46.24%)
After Hours: 5/1/2024, 8:18:16 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PAXMEDICA INC (PXMD).
Forecast Snapshot
Consensus Price Target
$3.06
+ 344.57% Upside
Next Earnings Forecast
Release DateMay 13, 2024
PeriodQ1 / 2024
EPS Estimate-$0.44
Revenue Estimate
ChartMill Buy Consensus
%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$3.06
Upside
+ 344.57%
From current price of $0.69 to mean target of $3.06, Based on analyst forecasts
Low
$3.03
Median
$3.06
High
$3.15
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
null analysts have analysed PXMD and the average price target is 3.06 USD. This implies a price increase of 344.57% is expected in the next year compared to the current price of 0.6883.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
%
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-12-04 | HC Wainwright & Co. | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 13, 2024
PeriodQ1 / 2024
EPS Estimate-$0.44
Revenue EstimateN/A
Revenue Q2QN/A
EPS Q2QN/A
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | |||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -220K | -600K -172.73% | -5.56M -826.67% | -7.2M -29.50% | -10.61M -47.36% | -16.145M -52.17% | N/A | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A 88.34% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.44 | -0.31 | -0.22 | -0.21 85.23% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
PAXMEDICA INC / PXMD Forecast FAQ
What is the average price target for PAXMEDICA INC (PXMD) stock?
null analysts have analysed PXMD and the average price target is 3.06 USD. This implies a price increase of 344.57% is expected in the next year compared to the current price of 0.6883.
Can you provide the upcoming earnings date for PAXMEDICA INC?
PAXMEDICA INC (PXMD) will report earnings on 2024-05-13.